Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease.
Drug Saf. 2006;29(12):1133-52. doi: 10.2165/00002018-200629120-00005.
Drug Saf. 2006.
PMID: 17147460
Review.